Insiders · ABT

ABT insider transactions

Abbott Laboratories (ABT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

ABT insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Abbott Laboratories, latest first. Follow anyone to get their next filing.

• Mary K MorelandExecutive Vice President-$900K
• John G StrattonDirector+$174K
• Patricia Paola GonzalezDirector, since August 2021
• Kevin T ConroyDirector, since April 2026
• Nita AhujaDirector, since December 2025
• Michael F RomanDirector, since April 2021
• John A. Mccoy Jr.Vice President and Controller, since September 2023-$207K
• Philip P BoudreauEVP and CFO+$201K-$2.61M
• Robert B FordChairman and CEO, Director+$2.01M-$111M
• Louis H. MorroneExecutive Vice President, since July 2021-$5.57M
• Elizabeth C. CushmanEVP, GC and Secretary, since June 2025-$30.4K
• Daniel J StarksDirector+$2.01M-$31.9M
• Michael O'GradyDirector, since April 2023
• Nancy McKinstryDirector
• Darren W McDewDirector
• Michelle KumbierDirector+$250K
• Sally E. BlountDirector-$337K
• Claire Babineaux-FontenotDirector, since September 2022
• Robert J AlpernDirector
• Jacob A OrvilleSenior Vice President, since March 2026
• Eric ShroffSenior Vice President, since March 2025-$363K
• Christopher J ScogginsExecutive Vice President, since December 2025-$5.55M
• Salvadori Daniel Gesua SiveEVP and Group President-$19.9M
• Lisa D EarnhardtEVP and Group President-$15.1M
• Andrea F WainerRetired EVP-$21.5M
• Hubert L AllenExecutive Vice President, GC-$68.3M
• Funck, Jr. Robert E.Executive Vice President-$1.18M
• Randel William WoodgriftOfficer-$3.87M
• Alejandro D WellischOfficer
• Jared WatkinOfficer-$11.8M
• Julie L. TylerOfficer, since July 2021-$162K
• Michael J PedersonOfficer-$2.97M
• Fernando MateusOfficer, since December 2021-$268K
• Joseph J ManningOfficer-$8.2M
• Sammy KaramOfficer-$4.14M
• John F GinascolOfficer-$1.42M
• Michael D DaleOfficer-$3.01M
• John M CapekOfficer-$20.2M
• Christopher J. CalamariOfficer, since July 2021-$83.4K
• Gregory A AhlbergOfficer-$3.7M

Recent Form 3, 4, and 5 filings for ABT

• 2d
  EXECUTIVE VICE PRESIDENT Moreland Mary K sold $406,000 worth of Common shares without par value (3,500 units at $116.00), decreasing direct ownership by 3% to 100,791 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 37d
  SEC Form 4 filed by Director Stratton John G

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 37d
  SEC Form 4 filed by Director Gonzalez Patricia Paola

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 37d
  SEC Form 4 filed by Director Conroy Kevin T

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 37d
  SEC Form 4 filed by Director Ahuja Nita

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 37d
  SEC Form 4 filed by Director Roman Michael F

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 44d
  Director Conroy Kevin T covered exercise/tax liability with 52,507 units of Common shares without par value, decreasing direct ownership by 39% to 81,230 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 66d
  VICE PRESIDENT AND CONTROLLER Mccoy John A. Jr. covered exercise/tax liability with 52 units of Common shares without par value and sold $2,958 worth of Common shares without par value (27 units at $109.54), decreasing direct ownership by 0.32% to 24,549 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 66d
  EVP AND CFO Boudreau Philip P covered exercise/tax liability with 388 units of Common shares without par value, decreasing direct ownership by 0.55% to 70,784 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 73d
  CHAIRMAN AND CEO Ford Robert B exercised 398,832 units of Common shares without par value at a strike of $54.02 and sold $46,204,798 worth of Common shares without par value (398,832 units at $115.85) (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 87d
  EXECUTIVE VICE PRESIDENT Morrone Louis H. sold $642,506 worth of Common shares without par value (5,850 units at $109.83), decreasing direct ownership by 8% to 70,724 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 130d
  SEC Form 4 filed by Director Stratton John G

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 130d
  SEC Form 4 filed by Director Roman Michael F

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 130d
  SEC Form 4 filed by Director Gonzalez Patricia Paola

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 130d
  SEC Form 4 filed by Director Conroy Kevin T

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 130d
  SEC Form 4 filed by Director Ahuja Nita

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 130d
  EXECUTIVE VICE PRESIDENT Morrone Louis H. covered exercise/tax liability with 269 units of Common shares without par value, decreasing direct ownership by 0.35% to 76,574 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 132d
  EVP, GC AND SECRETARY Cushman Elizabeth C. covered exercise/tax liability with 560 units of Common shares without par value, decreasing direct ownership by 1% to 38,013 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 143d
  Director Stratton John G bought $173,640 worth of Common shares without par value (2,000 units at $86.82), increasing direct ownership by 9% to 23,319 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 193d
  SEC Form 4 filed by EXECUTIVE VICE PRESIDENT Moreland Mary K

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Conroy Kevin T was granted 2,286 units of Common shares without par value, increasing direct ownership by 2% to 133,737 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  New insider Conroy Kevin T claimed ownership of 131,451 units of Common shares without par value (SEC Form 3)

  3 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Stratton John G was granted 2,286 units of Common shares without par value, increasing direct ownership by 12% to 21,319 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Starks Daniel J bought $926,537 worth of Common shares without par value (10,000 units at $92.65) and was granted 2,286 units of Common shares without par value, increasing direct ownership by 0.18% to 6,751,103 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Roman Michael F was granted 2,286 units of Common shares without par value, increasing direct ownership by 27% to 10,764 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director O'Grady Michael was granted 2,286 units of Common shares without par value, increasing direct ownership by 43% to 7,603 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Mckinstry Nancy was granted 2,286 units of Common shares without par value, increasing direct ownership by 6% to 41,010 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Mcdew Darren W was granted 2,286 units of Common shares without par value, increasing direct ownership by 22% to 12,678 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Kumbier Michelle was granted 2,286 units of Common shares without par value, increasing direct ownership by 15% to 18,000 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Gonzalez Patricia Paola was granted 2,286 units of Common shares without par value, increasing direct ownership by 33% to 9,205 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Blount Sally E. was granted 2,286 units of Common shares without par value, increasing direct ownership by 7% to 36,344 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Babineaux-Fontenot Claire was granted 2,286 units of Common shares without par value, increasing direct ownership by 43% to 7,603 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 194d
  Director Ahuja Nita was granted 2,286 units of Common shares without par value (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 195d
  EVP AND CFO Boudreau Philip P bought $201,300 worth of Common shares without par value (2,200 units at $91.50) (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 220d
  SEC Form 4 filed by Stratton John G

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 220d
  SEC Form 4 filed by Roman Michael F

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 220d
  SEC Form 4 filed by Gonzalez Patricia Paola

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 220d
  SEC Form 4 filed by Alpern Robert J

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 220d
  SEC Form 4 filed by Ahuja Nita

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 228d
  SEC Form 4 filed by Orville Jacob A

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 228d
  SEC Form 3 filed by new insider Orville Jacob A

  3 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  Senior Vice President Shroff Eric covered exercise/tax liability with 1,384 units of Common shares without par value and sold $81,946 worth of Common shares without par value (709 units at $115.58), decreasing direct ownership by 5% to 39,164 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  EXECUTIVE VICE PRESIDENT Scoggins Christopher J covered exercise/tax liability with 4,997 units of Common shares without par value, decreasing direct ownership by 6% to 77,126 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  EVP AND GROUP PRESIDENT Salvadori Daniel Gesua Sive covered exercise/tax liability with 6,615 units of Common shares without par value and sold $102,288 worth of Common shares without par value (885 units at $115.58), decreasing direct ownership by 5% to 146,377 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  EXECUTIVE VICE PRESIDENT Morrone Louis H. covered exercise/tax liability with 4,040 units of Common shares without par value and sold $132,224 worth of Common shares without par value (1,144 units at $115.58), decreasing direct ownership by 6% to 76,843 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  EXECUTIVE VICE PRESIDENT Moreland Mary K covered exercise/tax liability with 4,630 units of Common shares without par value and sold $70,851 worth of Common shares without par value (613 units at $115.58), decreasing direct ownership by 5% to 104,291 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  VICE PRESIDENT AND CONTROLLER Mccoy John A. Jr. covered exercise/tax liability with 1,142 units of Common shares without par value and sold $67,614 worth of Common shares without par value (585 units at $115.58), decreasing direct ownership by 7% to 24,628 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  CHAIRMAN AND CEO Ford Robert B covered exercise/tax liability with 30,308 units of Common shares without par value, decreasing direct ownership by 9% to 306,461 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  EVP AND GROUP PRESIDENT Earnhardt Lisa D covered exercise/tax liability with 8,577 units of Common shares without par value, decreasing direct ownership by 9% to 90,407 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  EVP, GC AND SECRETARY Cushman Elizabeth C. covered exercise/tax liability with 1,421 units of Common shares without par value and sold $30,398 worth of Common shares without par value (263 units at $115.58), decreasing direct ownership by 4% to 38,573 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 250d
  EVP AND CFO Boudreau Philip P covered exercise/tax liability with 7,441 units of Common shares without par value, decreasing direct ownership by 9% to 71,172 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  Senior Vice President Shroff Eric was granted 10,873 units of Common shares without par value, increasing direct ownership by 36% to 41,257 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  EXECUTIVE VICE PRESIDENT Scoggins Christopher J was granted 18,502 units of Common shares without par value, increasing direct ownership by 29% to 82,123 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  EVP AND GROUP PRESIDENT Salvadori Daniel Gesua Sive was granted 21,644 units of Common shares without par value, increasing direct ownership by 16% to 153,877 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  EXECUTIVE VICE PRESIDENT Morrone Louis H. was granted 15,418 units of Common shares without par value, increasing direct ownership by 23% to 82,027 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  EXECUTIVE VICE PRESIDENT Moreland Mary K was granted 13,951 units of Common shares without par value, increasing direct ownership by 15% to 109,534 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  VICE PRESIDENT AND CONTROLLER Mccoy John A. Jr. was granted 5,373 units of Common shares without par value, increasing direct ownership by 26% to 26,355 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  CHAIRMAN AND CEO Ford Robert B was granted 83,464 units of Common shares without par value, increasing direct ownership by 33% to 336,769 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  EVP AND GROUP PRESIDENT Earnhardt Lisa D was granted 27,056 units of Common shares without par value, increasing direct ownership by 38% to 98,984 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)
• 255d
  EVP, GC AND SECRETARY Cushman Elizabeth C. was granted 15,031 units of Common shares without par value, increasing direct ownership by 60% to 40,257 units (SEC Form 4)

  4 - ABBOTT LABORATORIES (0000001800) (Issuer)